David C. Bean

1.1k total citations
34 papers, 824 citations indexed

About

David C. Bean is a scholar working on Molecular Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, David C. Bean has authored 34 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Medicine, 11 papers in Infectious Diseases and 9 papers in Molecular Biology. Recurrent topics in David C. Bean's work include Antibiotic Resistance in Bacteria (15 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Salmonella and Campylobacter epidemiology (4 papers). David C. Bean is often cited by papers focused on Antibiotic Resistance in Bacteria (15 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Salmonella and Campylobacter epidemiology (4 papers). David C. Bean collaborates with scholars based in Australia, United Kingdom and New Zealand. David C. Bean's co-authors include David W. Wareham, D. Krahé, David M. Livermore, Lucinda M. C. Hall, Lara Wakeling, Stephen R. Giddens, M. Millar, Enid Hennessy, John D. Klena and Marisa Haenni and has published in prestigious journals such as Applied and Environmental Microbiology, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

David C. Bean

34 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David C. Bean Australia 13 394 232 176 152 139 34 824
Marija Tonkić Croatia 17 369 0.9× 130 0.6× 198 1.1× 175 1.2× 138 1.0× 61 866
Mohamed Seif El-Din Ashour Egypt 14 351 0.9× 156 0.7× 218 1.2× 141 0.9× 91 0.7× 28 657
Dolla Karam Sarkis Lebanon 18 564 1.4× 138 0.6× 210 1.2× 236 1.6× 171 1.2× 40 983
Floriana Gona Italy 15 607 1.5× 214 0.9× 237 1.3× 298 2.0× 113 0.8× 28 976
Kira Kondratyeva Israel 6 716 1.8× 183 0.8× 270 1.5× 262 1.7× 157 1.1× 9 940
Hazrat Bilal Pakistan 15 270 0.7× 151 0.7× 161 0.9× 107 0.7× 121 0.9× 78 857
Usha Govinden South Africa 14 568 1.4× 102 0.4× 160 0.9× 239 1.6× 145 1.0× 33 773
Rebekah M. Martin United States 6 642 1.6× 222 1.0× 267 1.5× 250 1.6× 69 0.5× 13 935
Maud Nilsson Sweden 16 650 1.6× 154 0.7× 118 0.7× 281 1.8× 237 1.7× 27 846
Mohammad Mehdi Feizabadi Iran 15 511 1.3× 126 0.5× 202 1.1× 221 1.5× 121 0.9× 29 690

Countries citing papers authored by David C. Bean

Since Specialization
Citations

This map shows the geographic impact of David C. Bean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Bean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Bean more than expected).

Fields of papers citing papers by David C. Bean

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Bean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Bean. The network helps show where David C. Bean may publish in the future.

Co-authorship network of co-authors of David C. Bean

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Bean. A scholar is included among the top collaborators of David C. Bean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Bean. David C. Bean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wareham, David W., et al.. (2024). Aeromonas and mcr–3: A Critical Juncture for Transferable Polymyxin Resistance in Gram-Negative Bacteria. Pathogens. 13(11). 921–921. 2 indexed citations
2.
Greenhill, Andrew R., et al.. (2024). Isolation and characterization of enterococci from poultry reveals high incidence of Enterococcus thailandicus in Victoria, Australia. Journal of Applied Microbiology. 135(8). 3 indexed citations
3.
Wakeling, Lara, et al.. (2023). Microbial ecology of Australian commercial rice koji and soybean miso. FedUni ResearchOnline (Federation University Australia). 3(5). 207–221. 3 indexed citations
4.
Wakeling, Lara, et al.. (2023). Food safety considerations in the production of traditional fermented products: Japanese rice koji and miso. Journal of Food Safety. 43(4). 11 indexed citations
5.
6.
Bean, David C. & David W. Wareham. (2022). Draft genome sequence of a multidrug-resistant Pseudomonas aeruginosa producing blaSIM metallo-β-lactamase: London, UK. Journal of Global Antimicrobial Resistance. 29. 222–224. 4 indexed citations
7.
Bean, David C., Jane Hawkey, Rohan H. Clarke, et al.. (2020). Salmonella enterica Serovar Hvittingfoss in Bar-Tailed Godwits (Limosa lapponica) from Roebuck Bay, Northwestern Australia. Applied and Environmental Microbiology. 86(19). 8 indexed citations
8.
Bean, David C., et al.. (2019). Hypermucoviscous polymyxin-resistant Klebsiella pneumoniae from Kolkata, India: Genomic and phenotypic analysis. Journal of Global Antimicrobial Resistance. 17. 1–2. 9 indexed citations
9.
Clarke, Rohan H., et al.. (2019). Wild Australian birds and drug-resistant bacteria: characterisation of antibiotic-resistant Escherichia coli and Enterococcus spp. Emu - Austral Ornithology. 119(4). 384–390. 3 indexed citations
10.
Wareham, David W. & David C. Bean. (2010). Molecular typing of multi-drug resistant Acinetobacter baumannii from London hospitals. International Journal of Infectious Diseases. 14. e36–e36. 1 indexed citations
11.
Bean, David C., D. Krahé, & David W. Wareham. (2008). Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005 – 2006. Annals of Clinical Microbiology and Antimicrobials. 7(1). 13–13. 136 indexed citations
12.
Wareham, David W., et al.. (2008). Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance. European Journal of Clinical Microbiology & Infectious Diseases. 27(7). 607–612. 102 indexed citations
13.
Bean, David C. & David W. Wareham. (2008). Paradoxical effect of 1-(1-naphthylmethyl)-piperazine on resistance to tetracyclines in multidrug-resistant Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy. 63(2). 349–352. 12 indexed citations
14.
Giddens, Stephen R. & David C. Bean. (2006). Investigations into the in vitro antimicrobial activity and mode of action of the phenazine antibiotic d-alanylgriseoluteic acid. International Journal of Antimicrobial Agents. 29(1). 93–97. 39 indexed citations
15.
Bean, David C., et al.. (2005). Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man. Journal of Antimicrobial Chemotherapy. 56(5). 962–964. 95 indexed citations
16.
Bean, David C. & John D. Klena. (2005). Characterization of major clones of antibiotic-resistant Streptococcus pneumoniae in New Zealand by multilocus sequence typing. Journal of Antimicrobial Chemotherapy. 55(3). 375–378. 15 indexed citations
17.
Bean, David C.. (2004). Molecular characterization of penicillin non-susceptible Streptococcus pneumoniae in Christchurch, New Zealand. Journal of Antimicrobial Chemotherapy. 54(1). 122–129. 6 indexed citations
18.
Bean, David C.. (2002). Prevalence of erm(A) and mef(B) erythromycin resistance determinants in isolates of Streptococcus pneumoniae from New Zealand. Journal of Antimicrobial Chemotherapy. 50(4). 597–599. 15 indexed citations
19.
Bean, David C.. (1996). Law reform for all. 2 indexed citations
20.
Bean, David C., et al.. (1981). SULPHUR-ASPHALT PAVEMENTS PERFORMANCE AND RECYCLING (WITH DISCUSSION). 50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marija Tonkić Breakdown of academic impact, for papers by Mohamed Seif El-Din Ashour Breakdown of academic impact, for papers by Dolla Karam Sarkis Breakdown of academic impact, for papers by Floriana Gona Breakdown of academic impact, for papers by Kira Kondratyeva Breakdown of academic impact, for papers by Hazrat Bilal Breakdown of academic impact, for papers by Usha Govinden Breakdown of academic impact, for papers by Rebekah M. Martin Breakdown of academic impact, for papers by Maud Nilsson Breakdown of academic impact, for papers by Mohammad Mehdi Feizabadi
Rankless by CCL
2026